Differential contributions of the complement anaphylotoxin receptors C5aR1 and C5aR2 to the early innate immune response against Staphylococcus aureus infection

Pathogens

Volumn 4, Issue 4, 2015, Pages 722-738

  Horst, Sarah A ^a   Itzek, Andreas ^a   Klos, Andreas ^b   Beineke, Andreas ^c   Medina, Eva ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

C5a; C5aR1; C5aR2; Complement system; Neutrophils; Staphylococcus aureus

Indexed keywords

COMPLEMENT ANAPHYLOTOXIN RECEPTOR C5AR1; COMPLEMENT ANAPHYLOTOXIN RECEPTOR C5AR2; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ABSCESS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; BLOODSTREAM INFECTION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 84992470815     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens4040722     Document Type: Article

References (42)

1. Merle, N.S.; Church, S.E.; Fremeaux-Bacchi, V.; Roumenina, L.T. Complement system part I-Molecular mechanisms of activation and regulation. Front. Immunol. 2015, doi:10.3389/fimmu.2015.00262.
2. Figueroa, J.E.; Densen, P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 1991, 4, 359-395.
3. Tong, S.Y.; Davis, J.S.; Eichenberger, E.; Holland, T.L.; Fowler, V.G., Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015, 28, 603-661.
4. Von Kockritz-Blickwede, M.; Konrad, S.; Foster, S.; Gessner, J.E.; Medina, E. Protective role of complement C5a in an experimental model of Staphylococcus aureus bacteremia. J. Innate Immun. 2010, 2, 87-92.
5. Jongerius, I.; Kohl, J.; Pandey, M.K.; Ruyken, M.; van Kessel, K.P.; van Strijp, J.A.; Rooijakkers, S.H. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 2007, 204, 2461-2471.
6. Bestebroer, J.; Aerts, P.C.; Rooijakkers, S.H.; Pandey, M.K.; Kohl, J.; van Strijp, J.A.; de Haas, C.J. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell. Microbiol. 2010, 12, 1506-1516.
7. Guo, R.F.; Ward, P.A. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 2005, 23, 821-852.
8. Mollnes, T.E.; Brekke, O.L.; Fung, M.; Fure, H.; Christiansen, D.; Bergseth, G.; Videm, V.; Lappegard, K.T.; Kohl, J.; Lambris, J.D. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002, 100, 1869-1877.
9. Monsinjon, T.; Gasque, P.; Chan, P.; Ischenko, A.; Brady, J.J.; Fontaine, M.C. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J. 2003, 17, 1003-1014.
10. Shuster, D.E.; Kehrli, M.E., Jr.; Rainard, P.; Paape, M. Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli. Infect. Immun. 1997, 65, 3286-3292.
11. Bosmann, M.; Sarma, J.V.; Atefi, G.; Zetoune, F.S.; Ward, P.A. Evidence for anti-inflammatory effects of C5a on the innate Il-L7a/IL-23 axis. FASEB J. 2012, 26, 1640-1651.
12. Gerard, N.P.; Gerard, C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991, 349, 614-617.
13. Ohno, M.; Hirata, T.; Enomoto, M.; Araki, T.; Ishimaru, H.; Takahashi, T.A. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol. Immunol. 2000, 37, 407-412.
14. Ward, P.A. Functions of C5a receptors. J. Mol. Med. (Berl) 2009, 87, 375-378.
15. Monk, P.N.; Scola, A.M.; Madala, P.; Fairlie, D.P. Function, structure and therapeutic potential of complement C5a receptors. Br. J. Pharmacol. 2007, 152, 429-448.
16. Okinaga, S.; Slattery, D.; Humbles, A.; Zsengeller, Z.; Morteau, O.; Kinrade, M.B.; Brodbeck, R.M.; Krause, J.E.; Choe, H.R.; Gerard, N.P.; et al. C5L2, a nonsignaling C5a binding protein. Biochemistry 2003, 42, 9406-9415.
17. Cain, S.A.; Monk, P.N. The orphan receptor C5AR2 has high affinity binding sites for complement fragments C5a and C5a des-arg(74). J. Biol. Chem. 2002, 277, 7165-7169.
18. Johswich, K.; Martin, M.; Thalmann, J.; Rheinheimer, C.; Monk, P.N.; Klos, A. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J. Biol. Chem. 2006, 281, 39088-39095.
19. Gao, H.; Neff, T.A.; Guo, R.F.; Speyer, C.L.; Sarma, J.V.; Tomlins, S.; Man, Y.; Riedemann, N.C.; Hoesel, L.M.; Younkin, E.; et al. Evidence for a functional role of the second C5a receptor C5AR2. FASEB J. 2005, 19, 1003-1005.
20. Gerard, N.P.; Lu, B.; Liu, P.; Craig, S.; Fujiwara, Y.; Okinaga, S.; Gerard, C. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 2005, 280, 39677-39680.
21. Bamberg, C.E.; Mackay, C.R.; Lee, H.; Zahra, D.; Jackson, J.; Lim, Y.S.; Whitfeld, P.L.; Craig, S.; Corsini, E.; Lu, B.; et al. The C5a receptor (C5aR1) C5L2 is a modulator of C5aR1-mediated signal transduction. J. Biol. Chem. 2010, 285, 7633-7644.
22. Chen, N.J.; Mirtsos, C.; Suh, D.; Lu, Y.C.; Lin, W.J.; McKerlie, C.; Lee, T.; Baribault, H.; Tian, H.; Yeh, W.C. C5AR2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007, 446, 203-207.
23. Rittirsch, D.; Flierl, M.A.; Nadeau, B.A.; Day, D.E.; Huber-Lang, M.; Mackay, C.R.; Zetoune, F.S.; Gerard, N.P.; Cianflone, K.; Kohl, J.; et al. Functional roles for C5a receptors in sepsis. Nat. Med. 2008, 14, 551-557.
24. Li, R.; Coulthard, L.G.; Wu, M.C.; Taylor, S.M.; Woodruff, T.M. C5L2: A controversial receptor of complement anaphylatoxin, C5a. FASEB J. 2013, 27, 855-864.
25. von Kockritz-Blickwede, M.; Rohde, M.; Oehmcke, S.; Miller, L.S.; Cheung, A.L.; Herwald, H.; Foster, S.; Medina, E. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am. J. Pathol. 2008, 173, 1657-1668.
26. Bozic, C.R.; Kolakowski, L.F., Jr.; Gerard, N.P.; Garcia-Rodriguez, C.; von Uexkull-Guldenband, C.; Conklyn, M.J.; Breslow, R.; Showell, H.J.; Gerard, C. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 1995, 154, 6048-6057.
27. Borders, C.W.; Courtney, A.; Ronen, K.; Pilar Laborde-Lahoz, M.; Guidry, T.V.; Hwang, S.A.; Olsen, M.; Hunter, R.L., Jr.; Hollmann, T.J.; Wetsel, R.A.; et al. Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate. Scand. J. Immunol. 2005, 62, 123-130.
28. Huber-Lang, M.S.; Riedeman, N.C.; Sarma, J.V.; Younkin, E.M.; McGuire, S.R.; Laudes, I.J.; Lu, K.T.; Guo, R.F.; Neff, T.A.; Padgaonkar, V.A.; et al. Protection of innate immunity by C5aR1 antagonist in septic mice. FASEB J. 2002, 16, 1567-1574.
29. Ehrengruber, M.U.; Geiser, T.; Deranleau, D.A. Activation of human neutrophils by C3a and C5a. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst. FEBS Lett. 1994, 346, 181-184.
30. Seow, V.; Lim, J.; Iyer, A.; Suen, J.Y.; Ariffin, J.K.; Hohenhaus, D.M.; Sweet, M.J.; Fairlie, D.P. Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a. J. Immunol. 2013, 191, 4308-4316.
31. Hajishengallis, G.; Lambris, J.D. Microbial manipulation of receptor crosstalk in innate immunity. Nat. Rev. Immunol. 2011, 11, 187-200.
32. Spaan, A.N.; Henry, T.; van Rooijen, W.J.; Perret, M.; Badiou, C.; Aerts, P.C.; Kemmink, J.; de Haas, C.J.; van Kessel, K.P.; Vandenesch, F.; et al. The staphylococcal toxin panton-valentine leukocidin targets human C5a receptors. Cell Host Microbe. 2013, 13, 584-594.
33. Spaan, A.N.; Schiepers, A.; de Haas, C.J.; van Hooijdonk, D.D.; Badiou, C.; Contamin, H.; Vandenesch, F.; Lina, G.; Gerard, N.P.; Gerard, C.; et al. Differential interaction of the staphylococcal toxins Panton-Valentine leukocidin and gamma-hemolysin CB with human C5a receptors. J. Immunol. 2015, 195, 1034-1043.
34. Spaan, A.N.; Vrieling, M.; Wallet, P.; Badiou, C.; Reyes-Robles, T.; Ohneck, E.A.; Benito, Y.; de Haas, C.J.; Day, C.J.; Jennings, M.P.; et al. The staphylococcal toxins gamma-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat. Commun. 2014, 5, 5438.
35. de Haas, C.J.; Veldkamp, K.E.; Peschel, A.; Weerkamp, F.; Van Wamel, W.J.; Heezius, E.C.; Poppelier, M.J.; Van Kessel, K.P.; van Strijp, J.A. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 2004, 199, 687-695.
36. Veldkamp, K.E.; Heezius, H.C.; Verhoef, J.; van Strijp, J.A.; van Kessel, K.P. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate. Infect. Immun. 2000, 68, 5908-5913.
37. Postma, B.; Poppelier, M.J.; van Galen, J.C.; Prossnitz, E.R.; van Strijp, J.A.; de Haas, C.J.; van Kessel, K.P. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 2004, 172, 6994-7001.
38. Jonsson, I.M.; Arvidson, S.; Foster, S.; Tarkowski, A. Sigma factor b and rsbu are required for virulence in staphylococcus aureus-induced arthritis and sepsis. Infect. Immun 2004, 72, 6106-6111.
39. Horsburgh, M.J.; Aish, J.L.; White, I.J.; Shaw, L.; Lithgow, J.K.; Foster, S.J. Sigmab modulates virulence determinant expression and stress resistance: Characterization of a functional rsbu strain derived from staphylococcus aureus 8325-4. J. Bacteriol. 2002, 184, 5457-5467.
40. Hopken, U.E.; Lu, B.; Gerard, N.P.; Gerard, C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 1996, 383, 86-89.
41. Ulrich, R.; Seeliger, F.; Kreutzer, M.; Germann, P.G.; Baumgartner, W. Limited remyelination in theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (ng2)-positive putative oligodendroglial progenitor cells. Neuropathol. Appl. Neurobiol. 2008, 34, 603-620.
42. Kummerfeld, M.; Seehusen, F.; Klein, S.; Ulrich, R.; Kreutzer, R.; Gerhauser, I.; Herder, V.; Baumgartner, W.; Beineke, A. Periventricular demyelination and axonal pathology is associated with subependymal virus spread in a murine model for multiple sclerosis. Intervirology 2012, 55, 401-416.